AJU-S56 5%

DRUG2 trials

Sponsors

AJU Pharm Co., Ltd.

Conditions

Dry Eye Syndromes

Phase 2

Efficacy and Safety of AJU-S56 in Dry Eye Syndrome Patients

CompletedNCT06337981

AJU Pharm Co., Ltd.Dry Eye Syndromes

Start: 2021-11-22End: 2022-11-28Updated: 2024-04-29

Phase 3

Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients

RecruitingNCT06291194

AJU Pharm Co., Ltd.Dry Eye Syndromes

Start: 2023-11-10End: 2024-05-31Target: 396Updated: 2024-04-08